Clinical trials
2 active studies led by Exosystems, of 2 in all
Source: ClinicalTrials.gov, Studies with Exosystems (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Exosystems in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Exosystems or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by Exosystems, of 2 in all
Source: ClinicalTrials.gov, Studies with Exosystems (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Markets we cover where free public records show Exosystems: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Exosystems is in.
Stories on the topics Exosystems works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Read